Agilent Technologies Quikchange Multi Site-Directed Mutagenesis Kit - Commercial, 10 Rxn

Agilent Technologies Quikchange Multi Site-Directed Mutagenesis Kit - Commercial, 10 Rxn; Included Is A License For Limited Use. Novel, Robust Technology For Complex, Multi-Site Mutagenesis In A Single Reaction. This Kit Is For Commercial Entities Only, - Quikchange
The Original Quikchange Site-Directed Mutagenesis Kits Eliminate The Need For Subcloning Into M13-Based Bacteriophage Vectors And For Ss-Dna Rescue.
>80% Mutagenesis Efficiency For One Site; >55% Mutagenesis Efficiency For Three Mutations Simultaneouslyefficient And Accurate Linear Amplification Minimizes Unwanted Errors
This Makes Site-Directed Mutagenesis Studies Simple And Reliable Since It Allows Oligo-Mediated Introduction Of Site-Specific Mutations Into Virtually Any Double-Stranded Plasmid Dna.
The Xl Version Of The Kit Is Specialized For Efficient Mutagenesis Of Large (4 To 14 Kb) Or Otherwise Difficult-To Mutagenize Plasmid Templates And Features Components Specifically Designed For More Efficient Dna Replication And Bacterial Transformation.
The Quikchange Multi System Allows Mutagenesis At Multiple Sites (Up To 5) In A Single Round, Using A Single Oligonucleotide Per Site.
- SR (Additional S&H Or Hazmat Fees May Apply)